INMB
Price
$8.37
Change
-$0.43 (-4.89%)
Updated
Apr 19, 6:59 PM EST
11 days until earnings call
NTLA
Price
$21.57
Change
+$0.23 (+1.08%)
Updated
Apr 19, 6:59 PM EST
12 days until earnings call
Ad is loading...

INMB vs NTLA ᐉ Comparison: Which is Better to Invest?

Header iconINMB vs NTLA Comparison
Open Charts INMB vs NTLABanner chart's image
INmune Bio
Price$8.37
Change-$0.43 (-4.89%)
Volume$33.85K
CapitalizationN/A
Intellia Therapeutics
Price$21.57
Change+$0.23 (+1.08%)
Volume$724.81K
CapitalizationN/A
View a ticker or compare two or three
INMB vs NTLA Comparison Chart

Loading...

INMBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
INMB vs. NTLA commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMB is a StrongSell and NTLA is a Hold.

COMPARISON
Comparison
Apr 20, 2024
Stock price -- (INMB: $8.37 vs. NTLA: $21.57)
Brand notoriety: INMB and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INMB: 74% vs. NTLA: 96%
Market capitalization -- INMB: $151.45M vs. NTLA: $2.07B
INMB [@Biotechnology] is valued at $151.45M. NTLA’s [@Biotechnology] market capitalization is $2.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $550.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INMB’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • INMB’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, NTLA is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMB’s TA Score shows that 4 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • INMB’s TA Score: 4 bullish, 5 bearish.
  • NTLA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than INMB.

Price Growth

INMB (@Biotechnology) experienced а -19.44% price change this week, while NTLA (@Biotechnology) price change was -11.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.06%. For the same industry, the average monthly price growth was -5.49%, and the average quarterly price growth was +1224.51%.

Reported Earning Dates

INMB is expected to report earnings on Aug 06, 2024.

NTLA is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (-7.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for INMB with price predictions.
OPEN
A.I.dvisor published
a Summary for NTLA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NTLA($2.08B) has a higher market cap than INMB($151M). INMB YTD gains are higher at: -25.666 vs. NTLA (-29.255).
INMBNTLAINMB / NTLA
Capitalization151M2.08B7%
EBITDAN/AN/A-
Gain YTD-25.666-29.25588%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INMBNTLA
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 23 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
INMBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSPIX5.390.05
+0.94%
LoCorr Spectrum Income I
GCEYX15.92-0.04
-0.25%
AB Global Core Equity Advisor
EIVPX14.00-0.10
-0.71%
Parametric Volatil Risk Prm-Defensv I
BSPAX582.03-5.12
-0.87%
iShares S&P 500 Index Investor A
GRINX19.18-0.22
-1.13%
Victory Diversified Stock R